Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Stuart Walter Peltz. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Stuart Walter Peltz har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:PTCT / PTC Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | 54 903 |
US:HSAQ / Health Sciences Acquisitions Corp 2 | Director | 22 261 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Stuart Walter Peltz. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp OBIO / Orchestra BioMed Holdings, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i OBIO / Orchestra BioMed Holdings, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel OBIO / Orchestra BioMed Holdings, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i OBIO / Orchestra BioMed Holdings, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internkjøp PTCT / PTC Therapeutics, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i OBIO / Orchestra BioMed Holdings, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel PTCT / PTC Therapeutics, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i OBIO / Orchestra BioMed Holdings, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Stuart Walter Peltz som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −301 | 54 903 | −0,55 | 45,63 | −13 734 | 2 505 114 | |
2023-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −2 320 | 166 962 | −1,37 | 45,63 | −105 857 | 7 618 142 | |
2023-01-26 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −284 | 55 204 | −0,51 | 47,45 | −13 476 | 2 619 502 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −492 | 55 488 | −0,88 | 44,36 | −21 825 | 2 461 425 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 189 | 169 282 | −0,70 | 44,36 | −52 744 | 7 509 282 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −571 | 55 980 | −1,01 | 42,93 | −24 515 | 2 403 384 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 228 | 170 471 | −0,72 | 42,93 | −52 722 | 7 318 814 | |
2023-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −279 | 56 551 | −0,49 | 41,66 | −11 622 | 2 355 700 | |
2023-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 786 | 171 699 | −1,03 | 41,66 | −74 398 | 7 152 328 | |
2023-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 18 000 | 56 830 | 46,36 | ||||
2023-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 53 000 | 173 485 | 43,99 | ||||
2022-06-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −407 | 38 239 | −1,05 | 26,83 | −10 919 | 1 025 876 | |
2022-04-15 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −82 | 38 646 | −0,21 | 45,28 | −3 713 | 1 749 852 | |
2022-02-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −282 | 38 728 | −0,72 | 40,00 | −11 281 | 1 549 197 | |
2022-02-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 961 | 120 485 | −1,60 | 40,00 | −78 444 | 4 819 641 | |
2022-01-27 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −330 | 39 010 | −0,84 | 39,31 | −12 974 | 1 533 639 | |
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 63 000 | 63 000 | |||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 165 000 | 165 000 | |||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 16 800 | 39 340 | 74,53 | ||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −294 | 22 540 | −1,29 | 38,52 | −11 326 | 868 354 | |
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 44 000 | 122 446 | 56,09 | ||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 869 | 78 446 | −2,33 | 38,52 | −72 003 | 3 022 132 | |
2022-01-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −378 | 22 834 | −1,63 | 41,16 | −15 559 | 939 893 | |
2021-06-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 36 400 | 36 400 | |||||
2021-06-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 6 240 | 22 721 | 37,86 | ||||
2021-04-15 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 1 400 | 16 481 | 9,28 | ||||
2021-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −283 | 15 081 | −1,84 | 56,96 | −16 119 | 858 953 | |
2021-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 968 | 80 315 | −2,39 | 56,96 | −112 089 | 4 574 421 | |
2021-01-27 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −350 | 15 364 | −2,23 | 62,05 | −21 719 | 953 398 | |
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 23 100 | 23 100 | |||||
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 161 000 | 161 000 | |||||
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 3 960 | 15 714 | 33,69 | ||||
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 27 600 | 82 283 | 50,47 | ||||
2021-01-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −382 | 11 754 | −3,15 | 62,37 | −23 825 | 733 097 | |
2021-01-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −284 | 12 136 | −2,29 | 62,37 | −17 713 | 756 922 | |
2021-01-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 402 | 54 683 | −2,50 | 62,37 | −87 443 | 3 410 579 | |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −115 937 | 149 063 | −43,75 | 33,02 | −3 828 240 | 4 922 060 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −169 781 | 5 219 | −97,02 | 30,86 | −5 239 442 | 161 058 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 938 | 56 085 | −12,40 | 63,25 | −502 047 | 3 547 152 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −30 060 | 64 023 | −31,95 | 62,27 | −1 871 776 | 3 986 584 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −77 939 | 94 083 | −45,31 | 61,43 | −4 787 793 | 5 779 519 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 115 937 | 172 022 | 206,72 | 33,02 | 3 828 240 | 5 680 166 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 212 | 56 085 | −12,77 | 63,19 | −518 924 | 3 544 067 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −38 779 | 64 297 | −37,62 | 62,34 | −2 417 560 | 4 008 404 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −122 790 | 103 076 | −54,36 | 61,43 | −7 543 358 | 6 332 268 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 169 781 | 225 866 | 302,72 | 30,86 | 5 239 442 | 6 970 225 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −137 500 | 62 500 | −68,75 | 18,01 | −2 476 375 | 1 125 625 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −18 125 | 7 875 | −69,71 | 11,23 | −203 544 | 88 436 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −192 792 | 0 | −100,00 | 27,05 | −5 215 024 | |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −310 | 56 085 | −0,55 | 65,70 | −20 369 | 3 685 065 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 530 | 56 395 | −19,35 | 64,61 | −874 133 | 3 643 512 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 520 | 69 925 | −7,32 | 63,65 | −351 359 | 4 450 866 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 927 | 75 445 | −11,63 | 62,41 | −619 574 | 4 708 749 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −23 543 | 85 372 | −21,62 | 61,68 | −1 452 038 | 5 265 403 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −22 902 | 108 915 | −17,37 | 60,66 | −1 389 281 | 6 607 002 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −61 768 | 131 817 | −31,91 | 59,56 | −3 678 902 | 7 851 021 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 137 500 | 193 585 | 245,16 | 18,01 | 2 476 375 | 3 486 466 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −300 | 56 085 | −0,53 | 65,19 | −19 558 | 3 656 349 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 242 | 56 385 | −5,44 | 64,36 | −208 665 | 3 629 108 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −747 | 59 627 | −1,24 | 63,01 | −47 068 | 3 757 097 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 852 | 60 374 | −4,51 | 61,90 | −176 547 | 3 737 332 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 332 | 63 226 | −5,01 | 60,84 | −202 726 | 3 846 796 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 652 | 66 558 | −10,31 | 59,58 | −455 906 | 3 965 526 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 18 125 | 74 210 | 32,32 | 11,23 | 203 544 | 833 378 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 700 | 56 085 | −2,94 | 65,78 | −111 818 | 3 688 991 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −18 022 | 57 785 | −23,77 | 64,62 | −1 164 672 | 3 734 356 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 494 | 75 807 | −7,89 | 63,67 | −413 499 | 4 826 935 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 984 | 82 301 | −14,52 | 62,44 | −873 091 | 5 138 463 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −33 443 | 96 285 | −25,78 | 61,68 | −2 062 764 | 5 938 859 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −34 036 | 129 728 | −20,78 | 60,64 | −2 063 807 | 7 866 187 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −85 113 | 163 764 | −34,20 | 59,56 | −5 068 990 | 9 753 129 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 192 792 | 248 877 | 343,75 | 27,05 | 5 215 024 | 6 732 123 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −7 208 | 192 792 | −3,60 | 27,05 | −194 976 | 5 215 024 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −3 104 | 0 | −100,00 | 10,85 | −33 678 | |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −2 115 | 0 | −100,00 | 10,85 | −22 948 | |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −7 590 | 3 104 | −70,97 | 10,85 | −82 352 | 33 678 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −700 | 56 085 | −1,23 | 64,82 | −45 374 | 3 635 430 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 200 | 56 785 | −2,07 | 64,16 | −76 992 | 3 643 326 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −100 | 57 985 | −0,17 | 62,46 | −6 246 | 3 622 033 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 300 | 58 085 | −2,19 | 61,83 | −80 375 | 3 591 221 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 100 | 59 385 | −1,82 | 60,72 | −66 796 | 3 606 095 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 808 | 60 485 | −4,44 | 59,56 | −167 259 | 3 602 789 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 208 | 63 293 | 12,85 | 27,05 | 194 976 | 1 712 076 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −300 | 56 085 | −0,53 | 64,71 | −19 412 | 3 629 092 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 56 385 | −0,88 | 64,01 | −32 005 | 3 609 204 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −449 | 56 885 | −0,78 | 61,88 | −27 782 | 3 519 759 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −600 | 57 334 | −1,04 | 60,95 | −36 569 | 3 494 393 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 255 | 57 934 | −2,12 | 59,52 | −74 694 | 3 448 058 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 104 | 59 189 | 5,53 | 10,85 | 33 678 | 642 201 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 56 085 | −0,88 | 64,42 | −32 210 | 3 612 996 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 56 585 | −0,70 | 61,88 | −24 754 | 3 501 763 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 56 985 | −0,70 | 60,68 | −24 272 | 3 457 907 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −815 | 57 385 | −1,40 | 59,52 | −48 505 | 3 415 268 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 115 | 58 200 | 3,77 | 10,85 | 22 948 | 631 470 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −100 | 56 085 | −0,18 | 65,12 | −6 512 | 3 652 255 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 600 | 56 185 | −2,77 | 64,41 | −103 051 | 3 618 707 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 57 785 | −0,69 | 63,21 | −25 284 | 3 652 590 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 200 | 58 185 | −2,02 | 61,93 | −74 312 | 3 603 222 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 200 | 59 385 | −1,98 | 60,87 | −73 042 | 3 614 646 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 090 | 60 585 | −4,85 | 59,56 | −184 037 | 3 608 382 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 590 | 63 675 | 13,53 | 10,85 | 82 352 | 690 874 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −8 421 | 18 529 | −31,25 | 33,02 | −278 061 | 611 828 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −7 065 | 13 399 | −34,52 | 18,01 | −127 241 | 241 316 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −2 362 | 2 363 | −49,99 | 11,23 | −26 525 | 26 536 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −7 560 | 0 | −100,00 | 30,86 | −233 302 | |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −2 505 | 20 464 | −10,91 | 18,01 | −45 115 | 368 557 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −1 575 | 4 725 | −25,00 | 11,23 | −17 687 | 53 062 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −500 | 375 | −57,14 | 12,64 | −6 320 | 4 740 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −3 440 | 7 560 | −31,27 | 30,86 | −106 158 | 233 302 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −4 900 | 0 | −100,00 | 27,05 | −132 545 | |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 421 | 12 178 | −40,88 | 60,00 | −505 260 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 8 421 | 20 599 | 69,15 | 33,02 | 278 061 | 680 179 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 065 | 12 178 | −36,71 | 60,00 | −423 900 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 065 | 19 243 | 58,01 | 18,01 | 127 241 | 346 566 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 362 | 12 178 | −16,24 | 60,00 | −141 720 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 362 | 14 540 | 19,40 | 11,23 | 26 525 | 163 284 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 560 | 12 178 | −38,30 | 60,00 | −453 600 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 560 | 19 738 | 62,08 | 30,86 | 233 302 | 609 115 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 505 | 12 178 | −17,06 | 60,00 | −150 300 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 505 | 14 683 | 20,57 | 18,01 | 45 115 | 264 441 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 575 | 12 178 | −11,45 | 60,00 | −94 500 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 575 | 13 753 | 12,93 | 11,23 | 17 687 | 154 446 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 12 178 | −3,94 | 60,00 | −30 000 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 500 | 12 678 | 4,11 | 12,64 | 6 320 | 160 250 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 440 | 12 178 | −22,03 | 60,00 | −206 400 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 440 | 15 618 | 28,25 | 30,86 | 106 158 | 481 971 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 900 | 12 178 | −28,69 | 60,00 | −294 000 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 4 900 | 17 078 | 40,24 | 27,05 | 132 545 | 461 960 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 037 | 12 178 | −47,54 | 60,00 | −662 220 | 730 680 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 2 115 | −95,94 | 10,85 | −542 500 | 22 948 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 813 | 56 085 | −17,40 | 54,79 | −647 282 | 3 073 121 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 114 | 67 898 | −11,83 | 53,86 | −490 907 | 3 657 190 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −29 073 | 77 012 | −27,41 | 53,13 | −1 544 765 | 4 091 956 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 106 085 | 89,15 | 10,85 | 542 500 | 1 151 022 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −48 175 | 26 000 | −64,95 | 11,23 | −541 005 | 291 980 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −22 929 | 10 694 | −68,19 | 10,85 | −248 780 | 116 030 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −31 681 | 56 085 | −36,10 | 53,62 | −1 698 608 | 3 007 053 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −16 494 | 87 766 | −15,82 | 52,94 | −873 126 | 4 645 981 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 48 175 | 104 260 | 85,90 | 11,23 | 541 005 | 1 170 840 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 786 | 56 085 | −17,37 | 53,69 | −632 814 | 3 011 316 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 143 | 67 871 | −14,10 | 53,01 | −590 713 | 3 597 977 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 22 929 | 79 014 | 40,88 | 10,85 | 248 780 | 857 302 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −51 825 | 74 175 | −41,13 | 11,23 | −581 995 | 832 985 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −22 511 | 33 623 | −40,10 | 10,85 | −244 244 | 364 810 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −50 015 | 52 115 | −48,97 | 10,85 | −542 663 | 565 448 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −51 825 | 56 085 | −48,03 | 50,14 | −2 598 350 | 2 811 934 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 51 825 | 107 910 | 92,40 | 11,23 | 581 995 | 1 211 829 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −22 511 | 56 085 | −28,64 | 50,15 | −1 128 882 | 2 812 551 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 22 511 | 78 596 | 40,14 | 10,85 | 244 244 | 852 767 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −50 015 | 56 085 | −47,14 | 50,10 | −2 505 852 | 2 809 971 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 015 | 106 100 | 89,18 | 10,85 | 542 663 | 1 151 185 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −54 560 | 56 134 | −49,29 | 10,85 | −591 976 | 609 054 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −900 | 102 130 | −0,87 | 10,85 | −9 765 | 1 108 110 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −54 560 | 56 085 | −49,31 | 50,00 | −2 728 000 | 2 804 250 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 54 560 | 110 645 | 97,28 | 10,85 | 591 976 | 1 200 498 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −900 | 56 085 | −1,58 | 50,00 | −45 000 | 2 804 250 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 900 | 56 985 | 1,60 | 10,85 | 9 765 | 618 287 |
2020-08-10 | 3/A | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
22 261 | ||||||||
2020-08-03 | 3 | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
40 522 | ||||||||
2020-08-03 | 3 | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
40 522 | ||||||||
2020-08-03 | 3 | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
40 522 | ||||||||
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −50 000 | 103 030 | −32,67 | 10,85 | −542 500 | 1 117 876 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −50 000 | 103 030 | −32,67 | 10,85 | −542 500 | 1 117 876 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 401 | 56 085 | −30,32 | 55,93 | −1 364 748 | 3 136 834 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −25 599 | 80 486 | −24,13 | 55,48 | −1 420 233 | 4 465 363 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 106 085 | 89,15 | 10,85 | 542 500 | 1 151 022 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 106 085 | 89,15 | 10,85 | 542 500 | 1 151 022 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 403 | 56 085 | −30,32 | 55,94 | −1 365 177 | 3 137 563 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −25 597 | 80 488 | −24,13 | 55,48 | −1 419 994 | 4 465 072 |
2020-05-22 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −33 788 | 203 030 | −14,27 | 10,85 | −366 600 | 2 202 876 |
2020-05-22 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −33 788 | 56 085 | −37,60 | 50,00 | −1 689 400 | 2 804 250 |
2020-05-22 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 33 788 | 89 873 | 60,24 | 10,85 | 366 600 | 975 122 |
2020-05-20 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −6 284 | 236 818 | −2,58 | 10,85 | −68 181 | 2 569 475 |
2020-05-20 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 284 | 56 085 | −10,08 | 50,12 | −314 979 | 2 811 205 |
2020-05-20 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 6 284 | 62 369 | 11,20 | 10,85 | 68 181 | 676 704 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −109 928 | 243 102 | −31,14 | 10,85 | −1 192 719 | 2 637 657 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 985 | 56 085 | −3,42 | 51,01 | −101 253 | 2 860 840 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −107 943 | 58 070 | −65,02 | 50,33 | −5 432 339 | 2 922 431 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 109 928 | 166 013 | 196,00 | 10,85 | 1 192 719 | 1 801 241 |
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 28 600 | 28 600 | |||||
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 192 500 | 192 500 | |||||
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 4 855 | 22 957 | 26,82 | ||||
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 33 000 | 56 085 | 142,95 | ||||
2020-01-27 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −423 | 18 102 | −2,28 | 53,25 | −22 523 | 963 877 | |
2020-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −359 | 18 525 | −1,90 | 48,17 | −17 292 | 892 312 | |
2020-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −439 | 18 884 | −2,27 | 48,17 | −21 146 | 909 605 | |
2020-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 797 | 23 085 | −7,22 | 48,17 | −86 558 | 1 111 958 | |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −7 656 | 22 969 | −25,00 | 18,01 | −137 885 | 413 672 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −5 741 | 6 300 | −47,68 | 11,23 | −64 471 | 70 749 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −1 000 | 875 | −53,33 | 12,64 | −12 640 | 11 060 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −559 | 12 041 | −4,44 | 11,23 | −6 278 | 135 220 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −125 | 1 875 | −6,25 | 12,64 | −1 580 | 23 700 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −3 900 | 0 | −100,00 | 10,85 | −42 315 | |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 656 | 18 676 | −29,07 | 50,00 | −382 800 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 656 | 26 332 | 40,99 | 18,01 | 137 885 | 474 239 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 741 | 18 676 | −23,51 | 50,00 | −287 050 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 5 741 | 24 417 | 30,74 | 11,23 | 64 471 | 274 203 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 000 | 18 676 | −5,08 | 50,00 | −50 000 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 000 | 19 676 | 5,35 | 12,64 | 12 640 | 248 705 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −559 | 18 676 | −2,91 | 50,00 | −27 950 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 559 | 19 235 | 2,99 | 11,23 | 6 278 | 216 009 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −125 | 18 676 | −0,66 | 50,00 | −6 250 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 125 | 18 801 | 0,67 | 12,64 | 1 580 | 237 645 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 900 | 18 676 | −17,27 | 50,00 | −195 000 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 900 | 22 576 | 20,88 | 10,85 | 42 315 | 244 950 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 482 | 18 676 | −15,71 | 50,00 | −174 100 | 933 800 |
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 26 950 | 26 950 | |||||
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 55 000 | 55 000 | |||||
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 265 000 | 265 000 | |||||
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 4 620 | 22 158 | 26,34 | ||||
2019-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −409 | 17 538 | −2,28 | 34,75 | −14 213 | 609 446 | |
2019-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −339 | 17 947 | −1,85 | 34,75 | −11 780 | 623 658 | |
2019-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 764 | 24 882 | −6,62 | 34,75 | −61 299 | 864 650 | |
2018-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −2 230 | 26 646 | −7,72 | 18,03 | −40 207 | 480 427 | |
2018-01-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 200 000 | 200 000 | |||||
2017-01-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 126 000 | 126 000 | |||||
2017-01-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 21 600 | 28 876 | 296,87 | ||||
2016-01-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 175 000 | 175 000 | |||||
2015-06-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | −3 500 | 353 030 | −0,98 | ||||
2015-06-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 500 | 7 276 | 92,69 | 10,85 | 37 975 | 78 945 | |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −26 300 | 356 530 | −6,87 | |||
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 3 776 | −9,58 | 54,29 | −21 716 | 204 999 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 400 | 4 176 | −76,24 | 53,64 | −718 776 | 224 001 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 500 | 17 576 | −41,56 | 52,89 | −661 125 | 929 595 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 26 300 | 30 076 | 696,50 | 10,85 | 285 355 | 326 325 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −17 170 | 382 830 | −4,29 | |||
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −60 306 | 110 694 | −35,27 | |||
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 500 | 3 776 | −48,10 | 56,40 | −197 400 | 212 966 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −22 300 | 7 276 | −75,40 | 55,71 | −1 242 333 | 405 346 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −36 075 | 29 576 | −54,95 | 54,64 | −1 971 138 | 1 616 033 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 825 | 65 651 | −15,26 | 53,81 | −636 303 | 3 532 680 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 17 170 | 77 476 | 28,47 | 10,85 | 186 294 | 840 615 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 60 306 | 60 306 | 10,85 | 654 320 | 654 320 | |
2015-03-23 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 900 | 0 | −100,00 | 70,57 | −134 083 | |
2015-03-23 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 575 | 1 900 | −77,58 | 69,79 | −458 869 | 132 601 |
2015-03-23 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −38 725 | 8 475 | −82,04 | 68,96 | −2 670 476 | 584 436 |
2015-03-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 47 200 | −0,84 | 72,27 | −28 908 | 3 411 144 |
2015-03-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 200 | 47 600 | −6,30 | 71,48 | −228 736 | 3 402 448 |
2015-03-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −43 601 | 50 800 | −46,19 | 70,67 | −3 081 283 | 3 590 036 |
2015-01-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 300 000 | 300 000 | 51,00 | 15 300 000 | 15 300 000 | ||
2014-10-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 980 | 94 401 | −3,06 | 43,89 | −130 792 | 4 143 260 |
2014-10-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −18 621 | 97 381 | −16,05 | 43,06 | −801 820 | 4 193 226 |
2014-10-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −19 900 | 116 002 | −14,64 | 42,09 | −837 591 | 4 882 524 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 714 | 135 902 | −4,03 | 30,73 | −175 591 | 4 176 268 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 600 | 141 616 | −6,96 | 30,10 | −319 060 | 4 262 642 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 022 | 152 216 | −5,60 | 29,08 | −262 360 | 4 426 441 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −151 | 161 238 | −0,09 | 27,39 | −4 136 | 4 416 309 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −174 | 161 389 | −0,11 | 32,76 | −5 700 | 5 287 104 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −988 | 161 563 | −0,61 | 31,81 | −31 428 | 5 139 319 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 816 | 162 551 | −2,29 | 30,80 | −117 533 | 5 006 571 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 854 | 166 367 | −8,70 | 30,00 | −475 620 | 4 991 010 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 582 | 182 221 | −3,49 | 28,82 | −189 693 | 5 251 609 |
2014-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 200 000 | 200 000 | 27,05 | 5 410 000 | 5 410 000 | ||
2013-06-19 | 3 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
188 803 |